Type 2 diabetes trials in Taiwan

In Taiwan 36 Also abroad 1196

36 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Changhua, Chiayi City, Kaohsiung City, Taichung, Tainan, Taipei
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Changhua, Chiayi City, Kaohsiung City, Taichung, Tainan, Taipei
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
No phaseTaking people
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
Where
Many Locations
Age
18 years and over
People
50,000 worldwide
Run by
Bayer
See details and how to joinNCT06278207
Phase 3Taking people
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Where
Taichung, Taoyuan
Age
10 years to 17 years
People
170 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Where
Kaohsiung City, Kaohsiung Niao Sung Dist, Taipei, Taoyuan
Age
18 years and over
People
1,035 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Where
Chiayi City, Kaohsiung City, Kaohsiung Niao Sung Dist, Taichung, Tainan, Taipei, Taoyuan
Age
18 years and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00
Phase 3Taking people
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Where
Hsinchu
Age
18 years and over
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Where
Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Tainan County, Taipei, Taoyuan
Age
18 years and over
People
2,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Changhua, Chiayi City, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Taking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Chia-Yi City, Kaohsiung City, New Taipei City, Taichung, Taipei, Taoyuan
Age
18 years and over
People
11,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Where
Changhua, Kaohsiung City, Taichung, Tainan, Taipei, Zhubei
Age
18 years and over
People
1,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784270
Phase 3Taking people
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Where
Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan, Yung Kang City
Age
18 years and over
People
1,200 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00
Phase 3Taking people
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Where
Taipei
Age
10 years to 18 years
People
80 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07282613
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Changhua, Kaohsiung City, Taichung, Tainan, Tainan County, Taipei
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Where
Chiayi City, Kaohsiung City, Kaohsiung Niao Sung Dist, Taipei
Age
18 years and over
People
1,980 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00
No phaseTaking people
Patients With Type 2 Diabetes
Where
Taipei
Age
18 years and over
People
2,000
Run by
National Taiwan University Hospital
See details and how to joinNCT07245082
No phaseTaking people
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Where
Changhua, Kaohsiung City, Niaosong, Taichung, Tainan, Taipei, Taoyuan City
Age
18 years and over
People
35,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT03549754
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Where
Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan, Zhubei
Age
18 years and over
People
900 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Where
Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Tainan County, Taipei
Age
18 years and over
People
800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662044 · EU 2025-523936-37-00
No phaseNot yet taking people in Taiwan
The Relationship Between Psychological Well-being, Social Support, and Disease Self-management in Patients With Diabetic Nephropathy
Where
Taipei
Age
18 years and over
People
161
Run by
National Taiwan University Hospital
See details and how to joinNCT07726589
No phaseNot yet taking people in Taiwan
Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes
Where
Taichung
Age
18 years and over
People
71,775
Run by
Chung Shan Medical University
See details and how to joinNCT07708610
No phaseNot yet taking people in Taiwan
HCC Risk and Monitoring in Patients With Type 2 Diabetes
Where
Taipei
Age
18 years and over
People
2,400
Run by
National Taiwan University Hospital
See details and how to joinNCT07675187
No phaseNot yet taking people in Taiwan
AI-Assisted Antidiabetic Drug Consultation System for Glycemic Control in Type 2 Diabetes Patients Managed by Non-Specialist Physicians
Where
Taipei
Age
19 years to 80 years
People
400
Run by
National Taiwan University Hospital
See details and how to joinNCT07684690
No phaseEnrolling by invitation
Digital Health Solutions for Patients With Type 2 Diabetes
Where
Taoyuan
Age
20 years to 75 years
People
60
Run by
Chang Gung Memorial Hospital
See details and how to joinNCT07642830
No phaseTaking people
Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia
Where
Taichung
Age
45 years to 85 years
People
128
Run by
yueh chu wu
See details and how to joinNCT07398495